The Association Between Chlorhexidine Bathing and Central Line-Associated Infections in Medical Intensive Care Units

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

6930 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-04-12

Study Completion Date

2023-05-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

We conducted a retrospective observational cohort study assessing the relationship between regular bathing using 2% CHG wipes every other day and the occurrence of central line-associated infections (CLABSI) in patients within the medical intensive care unit (MICU).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Chlorhexidine Bathing to Prevent Hospital-acquired Infections: the CLEANS Study

NCT05142969

Chlorhexidine Hospital-Acquired Infection Surgery +1 more

UNKNOWN NA

Impact of Daily Bathing With Chlorhexidine in the Critical Patient

NCT02870062

Healthcare Associated Infections

UNKNOWN PHASE1

Daily Chlorexidine Bath for Health Care Associated Infection Prevention

NCT05485051

Health Care Associated Infection Ventilator Associated Pneumonia Central Line-associated Bloodstream Infection (CLABSI) +1 more

COMPLETED PHASE3

The Effectiveness of Chlorhexidine Gluconate on Prevention of Catheter-Related Bloodstream Infections

NCT05995080

Central Venous Catheter Related Bloodstream Infection Catheter-Related Infections Bloodstream Infection Due to Central Venous Catheter

UNKNOWN NA

Daily Chlorhexidine Bathing and Infection Rates in Critically-ill Patients

NCT02033187

Healthcare Associated Infections

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study defined the post-intervention period as July 1, 2017, to June 30, 2022. During this period, one of the three medical intensive care units (MICUs) in NTUH implemented chlorhexidine gluconate (CHG) bathing as part of their daily care routine (CHG group). This decision was made in response to a higher incidence rate of vancomycin-resistant Enterococcus (VRE) bacteremia observed in that particular MICU during the preceding six months (pre-intervention period: January 1, 2017, to June 30, 2017), compared to the other two MICUs. The remaining two MICUs continued to provide usual care, which involved bathing patients with towels soaked in water and soap on a daily basis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Central Line-associated Bloodstream Infection (CLABSI)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

chlorhexidine group

Patients were bathed one day involving the use of wipes soaked in a 2% chlorhexidine gluconate (CHG) solution and the next day using a towel soaked with water and soap during the MICU stays.

Chlorhexidine bathing

Intervention Type OTHER

The procedure involved pouring an entire bottle (200ml) of 2% CHG solution (PBF Biotech, Taipei, Taiwan) onto a pre-packed set of eight single-use cotton wipes before each bathing session. A minimum of six wipes were required to thoroughly cover the entire body, including the bilateral upper and lower extremities, front and back of the trunk, perineum, and buttocks.

usual care group

Patients were bathed with towels soaked in water and soap on a daily basis during the MICU stays.

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Chlorhexidine bathing

The procedure involved pouring an entire bottle (200ml) of 2% CHG solution (PBF Biotech, Taipei, Taiwan) onto a pre-packed set of eight single-use cotton wipes before each bathing session. A minimum of six wipes were required to thoroughly cover the entire body, including the bilateral upper and lower extremities, front and back of the trunk, perineum, and buttocks.

Intervention Type OTHER